DH
Therapeutic Areas
Elypta Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GAGome for RCC Monitoring | Renal Cell Carcinoma Recurrence Monitoring | Clinical Validation |
| GAGome for MCED | Multi-Cancer Early Detection | Clinical Validation |
| PREDI-LYNCH Project | Hereditary Multi-Cancer Screening (Lynch Syndrome) | Clinical Study |
| GAGome for Bladder Cancer Risk | Bladder Cancer Risk Stratification | Clinical Validation |
| GAGome for Lung Cancer Risk | Lung Cancer Risk Stratification | Clinical Validation |